#polyendrocrine metabolic ovarian syndrom

1 story

#access to medication #australia #glp-1 drugs #news #pbs #pharmaceutical benefits scheme #pmos #politics #posaa #weight-loss medications #women's health

Push for subsidised weight-loss drugs for PMOS
Australian advocates want GLP-1 medications funded on the PBS for women with polyendrocrine metabolic ovarian syndrome, but approval remains uncertain.
the Guardian · 1m